← Back to headlines
Boston Scientific Stock Plunges After Underwhelming Growth Guidance
Boston Scientific's stock saw a significant drop after the company reiterated its full-year growth guidance, which was perceived as underwhelming by investors.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
